Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCP | P55072 | 5/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 10/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22925694 | 1.00 | VCP (0.46) | VCPTRPV1ALOX5DGAT1HDAC1 | |
| SCHEMBL22925735 | 0.88 | VCP (0.46) | VCPTRPV1ALOX5DGAT1HDAC1 | |
| SCHEMBL31013371 | 0.88 | VCP (0.46) | VCPTRPV1ALOX5DGAT1HDAC1 | |
| SCHEMBL22925618 | 0.88 | TRPV1 (0.45) | VCPTRPV1ALOX5DGAT1HDAC1 | |
| SCHEMBL22925617 | 0.87 | VCP (0.46) | VCPTRPV1ALOX5DGAT1HDAC1 | |
| SCHEMBL22925576 | 0.86 | TRPV1 (0.47) | VCPTRPV1ALOX5DGAT1KDR | |
| SCHEMBL22925600 | 0.85 | TRPV1 (0.45) | VCPTRPV1ALOX5KDR | |
| SCHEMBL22925839 | 0.85 | KMT2A (0.52) | VCPTRPV1ALOX5DGAT1KDR | |
| SCHEMBL22925670 | 0.84 | HDAC1 (0.47) | VCPTRPV1DGAT1HDAC1HDAC6 | |
| SCHEMBL29696301 | 0.84 | HDAC1 (0.47) | VCPTRPV1DGAT1HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003986-A1 | INHIBITOR COMPOUNDS | Cincera Therapeutics Pty Ltd (AU) | 2022-06-01 | — | — | EP | disclosed |
| CN-114450281-A | Inhibitor compounds | 辛塞拉治疗私人有限公司 | 2022-05-06 | — | — | CN | disclosed |